Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3447)
All Articles published online
|
Feb 21, 2009 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qin TJ, An GL, Zhao XH, Tian F, Li XH, Lian JW, Pan BR, Gu SZ. Combined treatment of oxaliplatin and capecitabine in patients with metastatic esophageal squamous cell cancer. World J Gastroenterol 2009; 15(7): 871-876 [PMID: 19230050 DOI: 10.3748/wjg.15.871] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i7/871.htm |
| Number | Citing Articles |
| 1 |
D-W Zhang, H-L Li, Q Yao, W-L Yang, H-L Wang, D-X Zhai, Z-H Zhou. The Synergistic Effect of Recombinant Human Endostatin (YH-16) Combined with Oxaliplatin on Human Colorectal Carcinoma. Journal of International Medical Research 2010; 38(1): 111 doi: 10.1177/147323001003800113
|
| 2 |
|
| 3 |
Tak Yun, Ji-Youn Han, Jin Soo Lee, Hyun Lee Choi, Hyae Young Kim, Byung-Ho Nam, Heung Tae Kim. Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma. BMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-385
|
| 4 |
Femke M. de Man, Ruben A.G. van Eerden, Esther Oomen-de Hoop, Joris N. Veraart, Nadia van Doorn, Leni van Doorn, Ate van der Gaast, Ron H.J. Mathijssen. Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients. Cancers 2019; 11(6): 826 doi: 10.3390/cancers11060826
|
| 5 |
Ruyue Yang, Wenhui Yue, Dong Hu, Guidan Wang, Longfei Mao, Jiahe Huang, Huili Wang, Gaofeng Liang. Synthesis of compounds based on the active domain of cabotegravir and their application in inhibiting tumor cells activity. ChemistryOpen 2024; 13(7) doi: 10.1002/open.202300284
|
| 6 |
|
| 7 |
Ka On Lam, Wendy W. L. Chan, Tsz Him So, Dora L. W. Kwong. Esophageal Squamous Cell Carcinoma. Methods in Molecular Biology 2020; 2129: 321 doi: 10.1007/978-1-0716-0377-2_24
|
| 8 |
Zhihao Lu, Yanqiao Zhang, Qingxia Fan, Yueyin Pan, Da Jiang, Ping Lu, Jingdong Zhang, Xianglin Yuan, Jifeng Feng, Shujun Yang, Wenbin Yue, Lin Zhao, Yunhua Xu, Jinhua Luo, Lin Shen. Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trial. The Innovation 2022; 3(3): 100239 doi: 10.1016/j.xinn.2022.100239
|
| 9 |
Iago Dillion Lima Cavalcanti. Chemotherapy Protocols and Infusion Sequence. 2022; : 125 doi: 10.1007/978-3-031-10839-6_5
|
| 10 |
Setsuo Utsunomiya, Keisuke Uehara, Takuya Kurimoto, Ken Hirose, Masahide Fukaya, Yu Takahashi, Yoshiro Taguchi, Keita Itatsu, Masato Nagino. Synchronous rectal and esophageal cancer treated with chemotherapy followed by two-stage resection. World Journal of Clinical Cases 2013; 1(2): 87-91 doi: 10.12998/wjcc.v1.i2.87
|
| 11 |
Jianmin Tian, Kenneth K. Wang. Handbook of Gastrointestinal Cancer. 2012; : 1 doi: 10.1002/9781118423318.ch1
|
| 12 |
Usha Malhotra, Sarbajit Mukherjee, Christos Fountzilas, Patrick Boland, Austin Miller, Santosh Patnaik, Kristopher Attwood, Sai Yendamuri, Araba Adjei, Eric Kannisto, Mateusz Opyrchal, Peter Bushunow, Peter Loud, Renuka Iyer, Nikhil Khushalani. Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates. Molecular Cancer Therapeutics 2020; 19(1): 304 doi: 10.1158/1535-7163.MCT-19-0240
|
| 13 |
Su Jin Lee, Sungmin Kim, Moonjin Kim, Jeeyun Lee, Yeon Hee Park, Young-Hyuck Im, Se Hoon Park. Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1716-9
|
| 14 |
Rachel L. Blom, Sjoerd M. Lagarde, Kim van Oudenaarde, Jean H. G. Klinkenbijl, Maarten C. Hulshof, Hanneke W. van Laarhoven, Jacques J. Bergman, Olivier R. Busch, Mark I. van Berge Henegouwen. Survival After Recurrent Esophageal Carcinoma Has Not Improved Over the Past 18 Years. Annals of Surgical Oncology 2013; 20(8): 2693 doi: 10.1245/s10434-013-2936-3
|
| 15 |
|
| 16 |
Jialei Wang, Jianhua Chang, Hui Yu, Xianghua Wu, Huijie Wang, Wenhua Li, Dongmei Ji, Wei Peng. A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus. Cancer Chemotherapy and Pharmacology 2013; 71(4): 905 doi: 10.1007/s00280-013-2081-5
|
| 17 |
Wanghua Chen, Wenling Wang, Yuxin Li, Hongmin Dong, Gang Wang, Xiaokai Li. Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0608-x
|